NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 110 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,147,000 | +390.2% | 54,550 | +360.1% | 0.03% | +357.1% |
| Q2 2021 | $234,000 | -33.0% | 11,855 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $349,000 | -3.9% | 12,000 | 0.0% | 0.01% | -8.3% |
| Q4 2020 | $363,000 | +90.1% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2020 | $191,000 | -25.7% | 12,000 | -7.7% | 0.01% | -38.5% |
| Q2 2020 | $257,000 | +60.6% | 13,000 | 0.0% | 0.01% | +18.2% |
| Q1 2020 | $160,000 | -33.3% | 13,000 | 0.0% | 0.01% | -21.4% |
| Q4 2019 | $240,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |